First Pacific Advisors, LP has added 1,014,989 shares of $BDX to their portfolio, per a new SEC 13F filing. This disclosure reflects the funds' holdings for the 12-31-2025 report period. You can see the fund's full portfolio on Quiver Quantitative, and also track the largest institutional owners of $BDX.
BECTON, DICKINSON Hedge Fund Activity
We have seen 596 institutional investors add shares of BECTON, DICKINSON stock to their portfolio, and 918 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- WELLINGTON MANAGEMENT GROUP LLP added 5,174,944 shares (+9056.3%) to their portfolio in Q3 2025, for an estimated $968,594,268
- UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC removed 4,568,558 shares (-75.3%) from their portfolio in Q4 2025, for an estimated $886,620,051
- VANGUARD GROUP INC added 4,223,149 shares (+13.0%) to their portfolio in Q4 2025, for an estimated $819,586,526
- NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO added 4,137,888 shares (+23219.2%) to their portfolio in Q4 2025, for an estimated $803,039,924
- GENERATION INVESTMENT MANAGEMENT LLP removed 1,984,672 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $385,165,295
- JPMORGAN CHASE & CO removed 1,794,165 shares (-33.9%) from their portfolio in Q4 2025, for an estimated $348,193,601
- FIRST EAGLE INVESTMENT MANAGEMENT, LLC added 1,651,592 shares (+16.5%) to their portfolio in Q4 2025, for an estimated $320,524,459
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
BECTON, DICKINSON Insider Trading Activity
BECTON, DICKINSON insiders have traded $BDX stock on the open market 11 times in the past 6 months. Of those trades, 0 have been purchases and 11 have been sales.
Here’s a breakdown of recent trading of $BDX stock by insiders over the last 6 months:
- MICHAEL DAVID GARRISON (EVP & Pres Med.Essntl&BioPharm) has made 0 purchases and 3 sales selling 2,239 shares for an estimated $457,308.
- CLAIRE FRASER sold 917 shares for an estimated $171,937
- MICHAEL FELD (EVP, CRO & Pres. Life Sciences) has made 0 purchases and 6 sales selling 396 shares for an estimated $76,604.
- BERTRAM L SCOTT sold 217 shares for an estimated $38,317
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
BECTON, DICKINSON Government Contracts
We have seen $100,665,444 of award payments to $BDX over the last year.
Here are some of the awards which we have have seen pay out the most over the last year:
- INFUSION PUMPS AND SERVICES: $5,519,658
- INFUSION PUMPS MULTIPLE-AWARD IDIQ VISN 10 ORDER: $5,252,124
- INFUSION PUMPS: $5,057,297
- 8511358199!PHARMACY AUTOMATION MAINTENAN: $4,072,311
- FLEET REPLACEMENT INFUSION PUMPS: $3,010,650
To track government contracts to publicy traded companies, check out Quiver Quantitative's government contracts dashboard.
BECTON, DICKINSON Price Targets
Multiple analysts have issued price targets for $BDX recently. We have seen 10 analysts offer price targets for $BDX in the last 6 months, with a median target of $194.0.
Here are some recent targets:
- Matt Miksic from Barclays set a target price of $202.0 on 02/11/2026
- Joanna Wiensch from Citigroup set a target price of $198.0 on 02/11/2026
- Lawrence Biegelsen from Wells Fargo set a target price of $157.0 on 02/10/2026
- Robert Marcus from JP Morgan set a target price of $175.0 on 02/10/2026
- Matthew Taylor from Jefferies set a target price of $190.0 on 02/10/2026
- Jason Bednar from Piper Sandler set a target price of $170.0 on 02/10/2026
- Shagun Singh from RBC Capital set a target price of $172.0 on 02/10/2026
Note that there may be inaccuracies in these estimates due to filing errors by the funds, parsing errors by us, or other anomalies.
Check out Quiver Quantitative's $BDX ticker page for more data.
